m+Medelevator.RU
← Поиск публикаций
Neuron · 2018

Mutations in Chromatin Modifier and Ephrin Signaling Genes in Vein of Galen Malformation.

СтатьяПоддержка NIH: внешняя программаНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Duran Daniel, Zeng Xue, Jin Sheng Chih, Choi Jungmin, Nelson-Williams Carol, Yatsula Bogdan, Gaillard Jonathan, Furey Charuta Gavankar, Lu Qiongshi, Timberlake Andrew T, Dong Weilai, Sorscher Michelle A, Loring Erin, Klein Jennifer, Allocco August, Hunt Ava, Conine Sierra, Karimy Jason K, Youngblood Mark W, Zhang Jinwei, DiLuna Michael L, Matouk Charles C, Mane Shrikant, Tikhonova Irina R, Castaldi Christopher, López-Giráldez Francesc, Knight James, Haider Shozeb, Soban Mariya, Alper Seth L, Komiyama Masaki, Ducruet Andrew F, Zabramski Joseph M, Dardik Alan, Walcott Brian P, Stapleton Christopher J, Aagaard-Kienitz Beverly, Rodesch Georges, Jackson Eric, Smith Edward R, Orbach Darren B, Berenstein Alejandro, Bilguvar Kaya, Vikkula Miikka, Gunel Murat, Lifton Richard P, Kahle Kristopher T

Аннотация

Normal vascular development includes the formation and specification of arteries, veins, and intervening capillaries. Vein of Galen malformations (VOGMs) are among the most common and severe neonatal brain arterio-venous malformations, shunting arterial blood into the brain's deep venous system through aberrant direct connections. Exome sequencing of 55 VOGM probands, including 52 parent-offspring trios, revealed enrichment of rare damaging de novo mutations in chromatin modifier genes that play essential roles in brain and vascular development. Other VOGM probands harbored rare inherited damaging mutations in Ephrin signaling genes, including a genome-wide significant mutation burden in EPHB4. Inherited mutations showed incomplete penetrance and variable expressivity, with mutation carriers often exhibiting cutaneous vascular abnormalities, suggesting a two-hit mechanism. The identified mutations collectively account for ∼30% of studied VOGM cases. These findings provide insight into disease biology and may have clinical implications for risk assessment.

Предметные рубрики MeSH

ИП Урсолов Владлен Сергеевич

ИНН 500118482352 · ОГРНИП 314500117700049

Реквизиты и контакты